Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

7.08
Delayed Data
As of Dec 05
 +0.22 / +3.21%
Today’s Change
4.50
Today|||52-Week Range
11.69
+5.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues5.9M8.1M6.2M12.5M
 
 
 
 
 
Depreciation And Amortization526.9K597.4K786.5K877.8K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses19.9M23.0M24.6M31.9M
 
 
 
 
 
Research And Development15.6M18.2M19.6M27.0M
 
 
 
 
 
Total Operating Expenses20.5M23.6M25.4M32.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.5M-15.5M-19.2M-20.2M
 
 
 
 
 
Extraordinary Credit0.000.000.002.7K
 
 
Extraordinary Charge-3.5M-406.2K-113.8K0.00
 
 
 
 
Other Expenses-194.5K7.8M635.6K-566.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.3M-8.0M-18.7M-20.8M
 
 
 
 
 
Income Taxes-308.5K0.000.000.00
 
 
Net Income-18.0M-8.0M-18.7M-20.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS72.2M72.2M73.0M73.6M
 
 
 
 
 
Shares To Calculate EPS Diluted72.2M72.2M73.0M73.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.11-$0.26-$0.28
 
 
 
 
 
EPS Diluted-$0.25-$0.11-$0.26-$0.28